Joel Rogers, CPA

Joel D. Rogers, CPA has served as Chief Financial Officer since December 2019. Mr. Rogers previously worked at Osiris Therapeutics, Inc. (NASDAQ: OSIR), which was acquired by Smith & Nephew in April 2019, as Chief Financial Officer from May 2018 to October 2019 and Corporate Controller from October 2017 to May 2018. Mr. Rogers served as Corporate Controller at ARC Group Worldwide, Inc. (NASDAQ: ARCW) from August 2014 to October 2017. Prior to ARC Group Worldwide, Inc., Mr. Rogers served in accounting management roles at DigitalGlobe, Inc. (NYSE: DGI), Allos Therapeutics, Inc. (NASDAQ: ALTH), and Flex LTD. (NASDAQ: FLEX). Mr. Rogers began his career as an auditor at Deloitte & Touche LLP. He holds a Bachelor of Arts (Accounting) from the University of Washington and a Master of Business Administration from Cornell University. He is a Certified Public Accountant (Colorado).